Medicus Pharma Ltd. (MDCX) closed at $1.89 on November 9, 2026, up 0.8% from the previous close, on volume of 58,049 shares (30-day average 1,586,840).
Data as of November 9, 2026.
Medicus Prioritizes CD228V in Capital-Efficiency Strategy
TipRanks (Mon, 9-Nov 8:15 AM ET)
Medicus Pharma to Highlight Rationale for CD228V Co-Development and License Agreement
ACCESS Newswire (Mon, 9-Nov 7:30 AM ET)
Medicus Prioritizes CD228V as Q3 Loss Narrows
TipRanks (Fri, 6-Nov 5:12 PM ET)
Medicus Pharma Ltd. GAAP EPS of -$11.64 misses by $5.40
Seeking Alpha News (Fri, 6-Nov 4:34 PM ET)
Medicus Pharma Reports Third Quarter 2026 Financial Results and Provides Corporate Update
ACCESS Newswire (Fri, 6-Nov 4:30 PM ET)
Medicus Pharma to Present at BIO-Europe 2026
Globe Newswire (Thu, 5-Nov 7:30 AM ET)
Globe Newswire (Wed, 4-Nov 4:05 PM ET)
Medicus Pharma Announces Proposed SkinJect Business Combination and Concurrent Financing
Globe Newswire (Wed, 4-Nov 8:30 AM ET)
Medicus Pharma to Present at BioFuture and Global Biotechnology Summit
Globe Newswire (Tue, 27-Oct 7:30 AM ET)
Medicus Pharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
Globe Newswire (Mon, 26-Oct 7:30 AM ET)
Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.
Medicus Pharma Ltd. trades on the NASDAQ stock market under the symbol MDCX.
As of November 9, 2026, MDCX stock price climbed to $1.88 with 58,049 million shares trading.
MDCX has a beta of 2.11, meaning it tends to be more sensitive to market movements. MDCX has a correlation of 0.02 to the broad based SPY ETF.
MDCX has a market cap of $3.58 million. This is considered a Sub-Micro Cap stock.
MDCX has underperformed the market in the last year with a price return of -98.4% while the SPY ETF gained +13.3%. MDCX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -87.4% and -24.9%, respectively, while the SPY returned -2.4% and -1.7%, respectively.
MDCX support price is $1.65 and resistance is $2.09 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MDCX shares will trade within this expected range on the day.
